Related Experiment Video
Updated: Aug 7, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
Oxidative stress in chronic cardiopathy associated with Chagas disease
Tiago Bittencourt de Oliveira1, Roberto Coury Pedrosa, Danilo Wilhelm Filho
1Departamento de Ecologia e Zoologia, Universidade Federal de Santa Catarina, Trindade, Florianópolis, 88040-900, Brazil.
Insights
Oxidative stress increases as Chagas heart disease progresses, indicated by declining glutathione levels. This suggests a depletion of the body's antioxidant defenses during chronic inflammation.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Background:
- Chagas disease involves chronic inflammation, mirroring autoimmune conditions.
- Oxidative stress, an imbalance in antioxidant and prooxidant defenses, is linked to inflammation in various diseases.
Purpose of the Study:
- To investigate the relationship between oxidative stress and the progression of chronic Chagas heart disease.
- To assess key components of the antioxidant system in patients at different disease stages.
Main Methods:
- Blood samples were analyzed from 90 subjects, including four groups of chronic Chagas heart disease patients (n=10 each) and matched healthy controls.
- Assayed antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), glutathione S-transferase (GST).
- Measured glutathione levels: reduced (GSH), oxidized (GSSG), and total glutathione (TG).
Main Results:
- Reduced glutathione (GSH) concentrations decreased as Chagas heart disease advanced.
- Glutathione peroxidase (GPx) activity varied, being higher in later disease stages and rheumatic heart disease, suggesting antioxidant depletion.
- While some enzyme activities (SOD, CAT, GR) showed no significant changes, overall antioxidant capacity appeared reduced in advanced Chagas disease compared to controls.
Conclusions:
- A general increase in oxidative stress is observed with the progression of Chagas disease.
- The findings highlight the role of oxidative stress in the pathogenesis of Chagas heart disease.
Background:
Chagas disease is characterized by chronic inflammation similar to autoimmune diseases. The imbalance between prooxidant and antioxidant defenses is known as oxidative stress, and is often associated with inflammatory processes of many diseases.
Methods:
The present work measured some components of the antioxidant system present in the blood of four groups of patients in different stages of chronic Chagas heart disease (n=10 each group), according to the modified Los Andes clinical-hemodynamic classification. Each group of chagasic patients was compared with four groups of healthy subjects, and chagasic group IV was compared to group V, characterized by rheumatic cardiac disease, giving a total of 90 subjects. Antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), glutathione S-transferase (GST), and the contents of reduced (GSH), oxidized (GSSG) and total glutathione (TG) were assayed.
Results:
SOD, CAT and GR activities showed essentially no differences among the four groups, however, intraerythrocytic GSH concentrations showed decreased values parallel to the progression of the disease. In addition, the glutathione peroxidase (GPx) activities were higher in groups III and V and lower in groups I, II and IV, also suggesting an antioxidant depletion with progression of the disease. In contrast, except for SOD and CAT activities, patients from group V showed a generally higher antioxidant capacity compared to the chagasic group IV.
Conclusion:
The results indicate a general increase of oxidative stress parallel to the progression of Chagas disease.
Related Concept Videos
American Trypanosomiasis
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology

